FIBCD1 ameliorates weight loss in chemotherapy-induced murine mucositis.
Maria C E AndersenMalene W JohansenThomas NissenAnders Bathum NexøeGunvor I MadsenGrith Lykke SorensenUffe HolmskovAnders SchlosserJesper Bonnet MoellerSteffen HusbyMathias RathePublished in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (2020)
Our findings suggest that FIBCD1 could ameliorate chemotherapy-induced gastrointestinal toxicity by reducing weight loss; however, the mechanism of this possible protective effect remains to be defined warranting additional investigations.